L 652343

Known as: L-652,343, L-652343

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

1988

1988

The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.

R. Barr, A. Black, +4 authors M. Greaves
British journal of clinical pharmacology
1988

Corpus ID: 46346908

1 3-hydroxy-5-trifluoromethyl-N-[2-(2-thienyl)-2-phenyl-ethenyl]-benzo(B) thiophene-2-carboxamide (L-652,343) is a 5-lipoxygenase… Expand

1988

1988

Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.

P. Bailey, A. Dallob, +7 authors R. Meurer
Arzneimittel-Forschung
1988

Corpus ID: 34125619

3-Hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)- benzo (b) thiophene-2-carboxamide (L-652,343) is an inhibitor of… Expand

1987

1987

L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood.

P. Gresele, J. Arnout, H. Deckmyn, J. Vermylen
Biochemical pharmacology
1987

Corpus ID: 40092173

1986

1986

L-652,343: a novel dual 5-lipoxygenase/cyclooxygenase inhibitor.

A. Tischler, P. Bailey, +7 authors E. Ham
Advances in prostaglandin, thromboxane, and…
1986

Corpus ID: 379082